← Eichor
Condition: Advanced Osteosarcoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Advanced Osteosarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07066982Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Phase 1 · 10 location(s) · Circle Pharma · NCT06577987Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma
Phase 1 · 1 location(s) · Sun Yat-sen University · NCT07648069KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma)
Phase 1 · 1 location(s) · TCRx Therapeutics Co.Ltd · NCT07596693PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Phase 2 · 1 location(s) · Ruijin Hospital · NCT06074692A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma
Phase 2 · 1 location(s) · Beijing Konruns Pharmaceutical Co., Ltd. · NCT06564272A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intr
Phase 2 · 1 location(s) · Vall d'Hebron Institute of Oncology · NCT06650514A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Phase 1 · 6 location(s) · SEED Therapeutics, Inc. · NCT07197554A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07193550Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
Phase 2 · 10 location(s) · Institut Bergonié · NCT05182164Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Phase 1 · 3 location(s) · BioEclipse Therapeutics · NCT04282044Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma
Phase 2 · 1 location(s) · Shanxi Province Cancer Hospital · NCT06637007Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcom
Phase 2 · 2 location(s) · M.D. Anderson Cancer Center · NCT05019703Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects Wit
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05621668Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive
Phase 1 · 1 location(s) · Fred Hutchinson Cancer Center · NCT07227571Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Phase 2 · 4 location(s) · Medical College of Wisconsin · NCT04040205Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05703854T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissu
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06474676XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Tran
Phase 2 · 1 location(s) · Northwestern University · NCT06571734Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Phase 1 · 36 location(s) · Inhibrx Biosciences, Inc · NCT03715933Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07602049HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT04995003Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas
Phase 1 · 1 location(s) · Tcelltech Inc. · NCT07052383
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.